Minglong Shao

1.8k total citations
69 papers, 1.2k citations indexed

About

Minglong Shao is a scholar working on Molecular Biology, Pharmacology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Minglong Shao has authored 69 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Molecular Biology, 16 papers in Pharmacology and 8 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Minglong Shao's work include Steroid Chemistry and Biochemistry (16 papers), Pharmacogenetics and Drug Metabolism (14 papers) and Microbial Metabolic Engineering and Bioproduction (13 papers). Minglong Shao is often cited by papers focused on Steroid Chemistry and Biochemistry (16 papers), Pharmacogenetics and Drug Metabolism (14 papers) and Microbial Metabolic Engineering and Bioproduction (13 papers). Minglong Shao collaborates with scholars based in China, United States and Hong Kong. Minglong Shao's co-authors include Zhiming Rao, Xian Zhang, Taowei Yang, Meijuan Xu, Zhenghong Xu, Chi Zhang, Xuemian Lu, Yi Tan, Xiaokun Li and Lu Cai and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Applied and Environmental Microbiology.

In The Last Decade

Minglong Shao

69 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Minglong Shao China 22 797 229 134 87 83 69 1.2k
Chenyue Liu China 22 798 1.0× 200 0.9× 125 0.9× 31 0.4× 166 2.0× 40 1.5k
Xiao‐Li Dong China 22 594 0.7× 132 0.6× 51 0.4× 24 0.3× 59 0.7× 64 1.3k
Sung‐Vin Yim South Korea 22 522 0.7× 136 0.6× 58 0.4× 26 0.3× 53 0.6× 61 1.3k
Jiekun Luo China 22 770 1.0× 183 0.8× 42 0.3× 23 0.3× 29 0.3× 68 1.6k
Soyoung Lee South Korea 16 500 0.6× 58 0.3× 53 0.4× 23 0.3× 56 0.7× 23 1.3k
Hong Nie China 22 568 0.7× 195 0.9× 57 0.4× 18 0.2× 44 0.5× 71 1.8k
Jiyeon Ock South Korea 22 538 0.7× 63 0.3× 149 1.1× 23 0.3× 144 1.7× 60 1.6k
Shujun Jiang China 22 467 0.6× 87 0.4× 108 0.8× 14 0.2× 59 0.7× 79 1.3k
Nishant P. Visavadiya United States 22 546 0.7× 163 0.7× 112 0.8× 17 0.2× 17 0.2× 40 1.3k

Countries citing papers authored by Minglong Shao

Since Specialization
Citations

This map shows the geographic impact of Minglong Shao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Minglong Shao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Minglong Shao more than expected).

Fields of papers citing papers by Minglong Shao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Minglong Shao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Minglong Shao. The network helps show where Minglong Shao may publish in the future.

Co-authorship network of co-authors of Minglong Shao

This figure shows the co-authorship network connecting the top 25 collaborators of Minglong Shao. A scholar is included among the top collaborators of Minglong Shao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Minglong Shao. Minglong Shao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Li, Xiaojing, Xiujuan Wang, Yongfeng Yang, et al.. (2024). Elevated plasma matrix metalloproteinase 9 in schizophrenia patients associated with poor antipsychotic treatment response and white matter density deficits. SHILAP Revista de lepidopterología. 10(1). 71–71. 3 indexed citations
3.
Su, Xi, Guanyu Wang, Jinming Li, et al.. (2024). Autophagy defects at weaning impair complement-dependent synaptic pruning and induce behavior deficits. Journal of Neuroinflammation. 21(1). 239–239. 6 indexed citations
4.
Zhou, Danyang, Xi Su, Yong Wu, et al.. (2023). Decreased CNNM2 expression in prefrontal cortex affects sensorimotor gating function, cognition, dendritic spine morphogenesis and risk of schizophrenia. Neuropsychopharmacology. 49(2). 433–442. 8 indexed citations
5.
Han, Yong, Yongfeng Yang, Han Shi, et al.. (2023). Cortical anatomical variations, gene expression profiles, and clinical phenotypes in patients with schizophrenia. NeuroImage Clinical. 39. 103451–103451. 4 indexed citations
6.
Zhang, Luwen, Xiaoyun Fan, Guanyu Wang, et al.. (2023). Lactate levels in the brain and blood of schizophrenia patients: A systematic review and meta-analysis. Schizophrenia Research. 264. 29–38. 8 indexed citations
8.
Song, Na, Jia Liu, Ke Zhang, et al.. (2022). The LIM Protein AJUBA is a Potential Oncogenic Target and Prognostic Marker in Human Cancer via Pan-Cancer Analysis. Frontiers in Cell and Developmental Biology. 10. 921897–921897. 2 indexed citations
9.
Song, Na, Kai Cui, Ke Zhang, et al.. (2022). The Role of m6A RNA Methylation in Cancer: Implication for Nature Products Anti-Cancer Research. Frontiers in Pharmacology. 13. 933332–933332. 32 indexed citations
10.
Li, Wenqiang, Xia Feng, Meng Song, et al.. (2021). Maternal immune activation alters adult behavior, intestinal integrity, gut microbiota and the gut inflammation. Brain and Behavior. 11(5). e02133–e02133. 30 indexed citations
11.
Zhang, Yan, Han Shi, Ge Yang, et al.. (2021). Associations between expression of indoleamine 2, 3-dioxygenase enzyme and inflammatory cytokines in patients with first-episode drug-naive Schizophrenia. Translational Psychiatry. 11(1). 595–595. 27 indexed citations
12.
Su, Xi, Wenqiang Li, Zhenlin Li, et al.. (2021). Chronic developmental exposure to low-dose ([C8mim][PF6]) induces neurotoxicity and behavioural abnormalities in rats. Ecotoxicology and Environmental Safety. 225. 112806–112806. 6 indexed citations
13.
Li, Wenqiang, Xi Su, Zhen Li, et al.. (2020). Solute Carrier Family 1 (SLC1A1) Contributes to Susceptibility and Psychopathology Symptoms of Schizophrenia in the Han Chinese Population. Frontiers in Psychiatry. 11. 559210–559210. 4 indexed citations
14.
Li, Wenqiang, Xiaoge Guo, Yunqing Hu, et al.. (2020). Behavioral abnormalities and phosphorylation deficits of extracellular signal-regulated kinases 1 and 2 in rat offspring of the maternal immune activation model. Physiology & Behavior. 217. 112805–112805. 4 indexed citations
15.
Zhang, Xian, Teng Bao, Xiaojing Zhao, et al.. (2019). Synthetic engineering of Corynebacterium crenatum to selectively produce acetoin or 2,3-butanediol by one step bioconversion method. Microbial Cell Factories. 18(1). 128–128. 9 indexed citations
16.
Li, Hongzhi, Xiao Han, Li Li, et al.. (2018). miR-23b promotes cutaneous wound healing through inhibition of the inflammatory responses by targeting ASK1. Acta Biochimica et Biophysica Sinica. 50(11). 1104–1113. 24 indexed citations
17.
Zhang, Chi, Zhifeng Huang, Junlian Gu, et al.. (2015). Fibroblast growth factor 21 protects the heart from apoptosis in a diabetic mouse model via extracellular signal-regulated kinase 1/2-dependent signalling pathway. Diabetologia. 58(8). 1937–1948. 99 indexed citations
18.
Shao, Minglong, Xian Zhang, Zhiming Rao, et al.. (2015). Enhanced Production of Androst-1,4-Diene-3,17-Dione by Mycobacterium neoaurum JC-12 Using Three-Stage Fermentation Strategy. PLoS ONE. 10(9). e0137658–e0137658. 30 indexed citations
20.
Yang, Hong, Minglong Shao, Liangmiao Chen, et al.. (2014). Screening Strategies for Thyroid Disorders in the First and Second Trimester of Pregnancy in China. PLoS ONE. 9(6). e99611–e99611. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026